Gyan Prakash Shrivastava
About Gyan Prakash Shrivastava
Data last updated:
Gyan Prakash Shrivastava is a Director at Global Drugs And Vaccines Private Limited (since 2022), Director at Nucleus Laboratories (India) Limted (since 2022) and Director at Nivaran Lifesciences Private Limited (since 2023). The companies operate in Pharma and Trading. The 3 current companies with reported revenue have a combined latest revenue of ₹7.46 Cr; the largest is Global Drugs And Vaccines Private Limited at ₹4.86 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Global Drugs And Vaccines Private Limited U51909UP2022PTC162092 | Director | 08 Apr 2022 | 2022 | ₹4.86 Cr (FY 2025) | Active |
 Nucleus Laboratories (India) Limted U24231UP1999PLC024944 | Director | 07 Mar 2022 | 1999 | ₹2.48 Cr (FY 2020) | Active |
| Nivaran Lifesciences Private Limited U51909UP2023PTC176589 | Director | 06 Jan 2023 | 2023 | ₹12.1 Lakh (FY 2025) | Active |
Board colleagues of Gyan Prakash Shrivastava
| Name | DIN | Company | Designation |
|---|---|---|---|
| Chandana Shrivastava | 09523772 | Global Drugs And Vaccines Private Limited , Nucleus Laboratories (India) Limted | Director |
| Madhulika Srivastava | 09566044 | Global Drugs And Vaccines Private Limited | Director |
| Ashish Kumar Singh | 01189756 | Nucleus Laboratories (India) Limted | Director |
| Debashish Saha | 10160104 | Nucleus Laboratories (India) Limted | Director |
| Himani Shukla | 11219612 | Nucleus Laboratories (India) Limted | Director |
| Amin Haider | 02037575 | Nivaran Lifesciences Private Limited | Director |
| Lokesh Sharma | 09853894 | Nivaran Lifesciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gyan Prakash Shrivastava
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gyan Prakash Shrivastava
Gyan Prakash Shrivastava currently holds 3 directorships: Global Drugs And Vaccines Private Limited (Director, since 08 Apr 2022, revenue ₹4.86 Cr (FY 2025)); Nucleus Laboratories (India) Limted (Director, since 07 Mar 2022, revenue ₹2.48 Cr (FY 2020)); Nivaran Lifesciences Private Limited (Director, since 06 Jan 2023, revenue ₹12.1 Lakh (FY 2025)).
Gyan Prakash Shrivastava was first appointed on 07 Mar 2022 as Director at Nucleus Laboratories (India) Limted. The most recent appointment on record is 06 Jan 2023 at Nivaran Lifesciences Private Limited.
The 3 current companies of Gyan Prakash Shrivastava that report revenue have a combined latest revenue of ₹7.46 Cr: Global Drugs And Vaccines Private Limited ₹4.86 Cr (FY 2025); Nucleus Laboratories (India) Limted ₹2.48 Cr (FY 2020); Nivaran Lifesciences Private Limited ₹12.1 Lakh (FY 2025).
The current boards of Gyan Prakash Shrivastava's companies include Chandana Shrivastava (Global Drugs And Vaccines Private Limited), Madhulika Srivastava (Global Drugs And Vaccines Private Limited), Ashish Kumar Singh (Nucleus Laboratories (India) Limted), Debashish Saha (Nucleus Laboratories (India) Limted), Himani Shukla (Nucleus Laboratories (India) Limted), Amin Haider (Nivaran Lifesciences Private Limited), among others.